BCL2 and neoplasm: The miR-34a is a key regulator of tumor suppression controlling the expression of several targets involved in the cell cycle (c-MYC, E2F, CDK4 and CDK6), apoptosis (BCL2 and SIRT1) and tumor-associated invasion (c-MET).